Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta

NCT ID: NCT03824873

Last Updated: 2020-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-01

Study Completion Date

2020-07-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

40 pregnant females at term diagnosed with morbidly adherent placenta and planned for elective cesarean section were recruited and randomized to 2 groups. Group A: Internal iliac ligation followed by cesarean hysterectomy. Group B: cesarean hysterectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

internal iliac artery ligation + cesarean hysterectomy

Group Type ACTIVE_COMPARATOR

Internal iliac artery ligation

Intervention Type PROCEDURE

Internal iliac artery ligation and cesarean hysterectomy

cesarean hysterectomy

Intervention Type PROCEDURE

cesarean hysterectomy

cesarean hysterectomy

Group Type ACTIVE_COMPARATOR

cesarean hysterectomy

Intervention Type PROCEDURE

cesarean hysterectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Internal iliac artery ligation

Internal iliac artery ligation and cesarean hysterectomy

Intervention Type PROCEDURE

cesarean hysterectomy

cesarean hysterectomy

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

cesarean hysterectomy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Placenta previa accreta
* Previous 2 cesarean section
* completed her family
* Hemoglobin \> 11 gm/dl
* Elective cesarean hysterectomy

Exclusion Criteria

* Anemia ( Hemoglobin \< 11 gm/dl)
* Not completed her family
* BMI \> 35 Kg/m2
* Bleeding tendency
* Emergengy cesarean section
* Thrombophilia
Minimum Eligible Age

25 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed S Sweed, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University Maternity Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AS1862

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PRP Gel in Wound Closure in Recurrent CS
NCT02775747 COMPLETED PHASE1/PHASE2
Emergency Intestinal Anastmosis
NCT07321743 COMPLETED NA
Abdominal Binder and Steps Trial
NCT04414384 COMPLETED NA